About ALCRESTA THERAPEUTICS, INC
Alcresta Therapeutics is a biotechnology company based in Massachusetts that develops enzyme-based products to address fat malabsorption in patients with rare diseases who require enteral feeding. Their flagship product, RELiZORB, is a digestive enzyme cartridge designed to mimic pancreatic lipase function.
Development of enzyme-based products for enteral nutritionDesign and production of RELiZORB, a patented microbead/enzyme technology for fat breakdownConducting clinical trials for various patient populations including neonates, children, and adults with conditions like cystic fibrosis, short bowel syndrome, and pancreatitisGenerating real-world evidence and preclinical data to support product efficacy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ALCRESTA THERAPEUTICS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.